Depletion of cerebral D-serine in non-ketotic hyperglycinemia: Possible involvement of glycine cleavage system in control of endogenous D-serine

Biochemical and Biophysical Research Communications

Volumn 231, Issue 3, 1997, Pages 793-796

  Iwama, Hisayuki ^a   Takahashi, Katsunobu ^a   Kure, Shigeo ^b   Hayashi, Fumihiko ^a   Narisawa, Kuniaki ^b   Tada, Keiya ^c   Mizoguchi, Masashi ^a   Takashima, Sachio ^a   Tomita, Urara ^a   Nishikawa, Toru ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NTT East Tohoku Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; GLYCINE CLEAVAGE SYSTEM; MERCAPTAMINE; SERINE;

AMINO ACID BRAIN LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERGLYCINEMIA; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 17144440475     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6184     Document Type: Article

References (23)

1. Hashimoto A., Nishikawa T., Hayashi T., Fujii N., Harada K., Oka T., Takahashi K. FEBS Lett. 296:1992;33-36.
2. Hashimoto A., Kumashiro S., Nishikawa T., Oka T., Takahashi K., Mito T., Takashima S., Doi N., Mizutani Y., Yamazaki T., Kaneko T., Ootomo E. J. Neurochem. 61:1993;348-351.
3. Hashimoto A., Nishikawa T., Oka T., Takahashi K. J. Neurochem. 60:1993;783-786.
4. Corrigan J. J. Science. 164:1969;142-149.
5. Kumashiro S., Hashimoto A., Nishikawa T. Brain Res. 681:1995;117-125.
6. Nishikawa T., Hashimoto A., Tanii Y., Umino A., Kashiwa A., Kumashiro S., Nishijima K., Oka T., Shirayama Y., Takahashi K. Development of Psychiatry Series, Vol. 10, The Biology of Schizophrenia. 1994;Elsevier, Amsterdam. p. 197-207.
7. Chouinard M. L., Gaitan D., Wood P. L. J. Neurochem. 61:1993;1561-1564.
8. Wood P. L., Hawkinson J. E., Goodnough. J. Neurochem. 67:1996;1485-1490.
9. Tada K. Enzyme. 38:1987;27-35.
10. Hayashi K., Tada K. Biochem. Int. 6:1983;225-230.
11. Yudkoff M., Nissim I., Schneider A., Segal S. Matabolism. 30:1981;1096-1103.
12. Lowry M., Hall D. E., Hall M. S., Brosnan J. T. Am. J. Physiolo. 252:1987;F304-309.
13. Kure S., Narisawa K., Tada K. J. Pediatr. 120:1992;95-98.
14. Perry T., Urquhart N., Hansen S. Pediat. Res. 12:1977;1192-1197.
15. Kemp J., Leeson P. Trends Pharmacol. Sci. 14:1993;20-25.
16. Daly E. C., Nadi N. S., Aprison M. H. J. Neurochem. 26:1976;179-185.
17. Sato K., Yoshida S., Fujiwara K., Tada T., Tohyama M. Brain Res. 567:1991;64-70.
18. Schell M. J., Molliver M. E., Snyder S. H. Proc. Natl. Acad. Sci. USA. 92:1995;3948-3952.
19. Homosb A., Johnston M. V., McDonald J. W., Francamano C., Niedermeyer E., Valle D. (abstract of 20th Annual Meeting of Child Neurology Society). Ann. Neurol. 30:1991;469.
20. Ohya Y., Ochi N., Mizutani N., Hayakawa C., Watanabe K. Pediatr. Neurol. 7:1991;65-68.
21. Tada K., kure S. J. Inher. Metab. Dis. 16:1993;691-703.
22. R. Petersen, R. Stillman, 1978, Phencyclidine (PCP) Abuse: An Appraisal, National Institute on Drug Abuse Research Monograph 21, U.S. Government Printing Office, Washington, DC.
23. Hashimoto A., Oka T., Nishikawa T. Eur. J. Neurosci. 7:1995;1657-1663.